BIT
ABEO icon

BlackRock Institutional Trust’s Abeona Therapeutics ABEO Stock Holding History

BlackRock Institutional Trust’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$982K Buy
8,102
+5,275
+187% +$826K ﹤0.01% 3298
2016
Q3 		$424K Hold
2,827
– – ﹤0.01% 3516
2016
Q2 		$167K Sell
2,827
-2,807
-50% -$192K ﹤0.01% 3654
2016
Q1 		$361K Sell
5,634
-62
-1% -$4.11K ﹤0.01% 3521
2015
Q4 		$478K Buy
5,696
+134
+2% +$13.4K ﹤0.01% 3515
2015
Q3 		$563K Buy
5,562
+2,992
+116% +$397K ﹤0.01% 3471
2015
Q2 		$325K Buy
+2,570
New +$386K ﹤0.01% 3571

Other funds holding ABEO

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock Institutional Trust's ABEO Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Abeona Therapeutics (ABEO) stake by 187% in Q4 2016, buying an estimated $826K and bringing the position to 8,102 shares worth $982K. The position accounts for ﹤0.01% of the portfolio, ranked #3298.

BlackRock Institutional Trust first reported a position in ABEO in Q2 2015 and has held it in 7 quarters since. 54 funds tracked by Wall St. Rank hold ABEO as of Q4 2016.

  • BlackRock Institutional Trust held 8,102 shares of Abeona Therapeutics worth $982K as of Q4 2016.
  • BlackRock Institutional Trust bought 5,275 Abeona Therapeutics shares in Q4 2016, an estimated $826K.
  • Abeona Therapeutics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3298 holding.
  • BlackRock Institutional Trust first reported a position in Abeona Therapeutics in Q2 2015 and has held it in 7 quarters since.
  • 54 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.